Microbiologically documented nosocomial infections after coronary artery bypass surgery without cardiopulmonary bypass (original) (raw)

Abstract

It included all adult patients who underwent coronary artery bypass grafting with no valve surgery and without the use of cardiopulmonary bypass during a period of 3 years. Case patients were those with development of microbiologically documented nosocomial infections. Various variables were examined as possible risk factors for nosocomial infections. Results: Twenty-one of 782 studied patients (2.7%) acquired 26 microbiologically documented nosocomial infections after off-pump coronary artery bypass grafting. Eight of 782 studied patients had pneumonia (1.02%), 7 of 782 (0.90%) had bacteremia, 4 of 782 (0.51%) had superficial wound infection at the sternotomy site, 4 of 782 (0.51%) had urinary tract infection, 2 of 782 (0.26%) had mediastinitis, and 1 of 782 (0.13%) had pressure sore infection. Twenty-one infections were monomicrobial, whereas 5 were polymicrobial. All polymicrobial infections were wound infections. There was a statistically significant difference in mortality between patients with and without nosocomial infection (23.8% vs 1.2%, P Ͻ .001). Clinical response of the infection to the treatment administered was observed in 21 of 26 episodes (80.8%) in 21 patients. A backward stepwise multivariable logistic regression model showed that independent risk factors (P Ͻ .05) associated with development of microbiologically documented nosocomial infection were arterial hypertension, previous vascular surgery, urgent operation, postoperative atrial fibrillation, number of inotropes used during and after operation, transfusion of fresh-frozen plasma during the intensive care unit stay, and intensive care unit stay until development of infection. Conclusion: Nosocomial infection after off-pump coronary artery bypass grafting is an uncommon but potentially life-threatening complication. The identification of independent risk factors, including arterial hypertension, associated with development of postoperative infection may help in the development of clinical strategies for the prevention, early diagnosis, and treatment of these infections. C oronary artery bypass grafting (CABG) on a beating heart (off-pump CABG, or OPCAB) has become common in the last 10 years in an attempt to decrease the complications associated with the use of extracorporeal circulation. OPCAB is associated with a significant reduction in inflammatory response, a fact supported by decreased production of interleukin 8, lower postoperative concentrations of elastase, and lower postoperative white blood cell, neutrophil, and monocyte counts. 1,2 A recent meta-analysis of 37 randomized trials that

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (21)

  1. Menasche P. The systemic factor: the comparative roles of cardiopul- monary bypass and off-pump surgery in the genesis of patient injury during and following cardiac surgery. Ann Thorac Surg. 2001;72: S2260-70.
  2. Ascione R, Lloyd CT, Underwood MJ, Lotto AA, Pitsis AA, Angelini GD. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg. 2000;69:1198- 204.
  3. Cheng DC, Bainbridge D, Martin JE, Novick RJ; Evidence-Based Perioperative Clinical Outcomes Research Group. Does off-pump cor- onary artery bypass reduce mortality, morbidity, and resource utiliza- tion when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology. 2005;102:188- 203.
  4. Mack MJ, Pfister A, Bachand D, Emery R, Magee MJ, Connolly M, et al. Comparison of coronary bypass surgery with and without car- diopulmonary bypass in patients with multivessel disease. J Thorac Cardiovasc Surg. 2004;127:167-73.
  5. Prapas SN, Anagnostopoulos CE, Kotsis VN, Stavropoulos GP, Sid- iropoulos AV, Ananiadou OG, et al. A new pattern for using both thoracic arteries to revascularize the entire heart: the -graft. Ann Thorac Surg. 2002;73:1990-2.
  6. Horan TC, Gaynes RP. Surveillance of nosocomial infections. Appen- dix A: CDC definitions of nosocomial infections. In: Mayahall CG. Hospital epidemiology and infection control. Philadelphia: Lippincot Williams & Wilkins; 2004. p. 1659-702.
  7. Fowler VG Jr, O'Brien SM, Muhlbaier LH, Corey GR, Ferguson TB, Peterson ED. Clinical predictors of major infections after cardiac surgery. Circulation. 2005;112(9 Suppl):I358-65.
  8. Kollef MH, Sharpless L, Vlasnik J, Pasque C, Murphy D, Fraser VJ. The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest. 1997;112:666-75.
  9. Gol MK, Karahan M, Ulus AT, Erdil N, Iscan Z, Karabiber N, et al. Bloodstream, respiratory, and deep surgical wound infections after open heart surgery. J Card Surg. 1998;13:252-9.
  10. Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG, et al. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg. 1997;226:501-11.
  11. Elahi M, Hadjinikolaou L, Galinanes M. Incidence and clinical con- sequences of atrial fibrillation within 1 year of first-time isolated coronary bypass surgery. Circulation. 2003;108(Suppl 1):II207-12.
  12. Bender JS. Supraventricular tachyarrhythmias in the surgical intensive care unit: an under-recognized event. Am Surg. 1996;62:73-5.
  13. Engelmann MD, Svendsen JH. Inflammation in the genesis and per- petuation of atrial fibrillation. Eur Heart J. 2005;26:2083-92.
  14. Wazni O, Martin DO, Marrouche NF, Shaaraoui M, Chung MK, Almahameed S, et al. C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion. Heart. 2005;91: 1303-5.
  15. Abdelhadi RH, Gurm HS, Van Wagoner DR, Chung MK. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postopera- tively. Am J Cardiol. 2004;93:1176-8.
  16. Ryan T, Mc Carthy JF, Rady MY, Serkey J, Gordon S, Starr NJ, et al. Early bloodstream infection after cardiopulmonary bypass: frequency rate, risk factors, and implications. Crit Care Med. 1997;25:2009-14.
  17. Michalopoulos A, Stavridis G, Geroulanos S. Severe sepsis in cardiac surgical patients. Eur J Surg. 1998;164:217-22.
  18. Sreeram GM, Welsby IJ, Sharma AD, Phillips-Bute B, Smith PK, Slaughter TF. Infectious complications after cardiac surgery: lack of association with fresh frozen plasma or platelet transfusions. J Car- diothorac Vasc Anesth. 2005;19:430-4.
  19. Michalopoulos A, Geroulanos S, Rosmarakis ES, Falagas ME. Fre- quency, characteristics, and predictors of microbiologically docu- mented nosocomial infections after cardiac surgery. Eur J Cardiotho- rac Surg. 2006;29:456-60.
  20. Bratzler DW, Houck PM; Surgical Infection Prevention Guidelines Writers Workgroup. Antimicrobial prophylaxis for surgery: an advi- sory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004;38:1706-15.
  21. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 1999;56:1839-88.